Very Early Molecular Responses During The First Two Months Of Therapy Are Highly Predicitive Of Deep Molecular Responses In Newly-Diagnosed Chronic Myeloid Leukemia In Chronic Phase(CML-CP) Patients Treated Upfront With Nilotinib

Sastre Moral, José Luis

Estatísticas

Estatísticas

Ver Estatísticas de uso

Identificadores

Identificadores

URI: http://hdl.handle.net/20.500.11940/3595

ISSN: 0006-4971

Rexistro completo

Servizos

Servizos

RIS

Mendeley

Linksolver

Data de publicación

2013

Título da revista

Blood

Tipo de contido

Publicación de congreso